Director of Research Site Partnership
Sarah Cannon Research Institute
Summary
As the Director of Research Site Partnerships you serve as the executive relationship owner for a portfolio of oncology research sites. You will drive site engagement, alignment, and performance through strategic partnership and a focus on clinical trial enrollment growth. You will operate as a strategic account leader, navigating complex situations, influencing outcomes, and partnering across leadership to align priorities, remove barriers, and deliver value in a matrixed environment.
Job description
Your responsibilities will include:
- Manage a portfolio of approximately 5–6 oncology research sites, depending on complexity
- Serve as senior relationship owner for assigned sites
- Build executive-level partnerships with site leadership, physicians, research teams, and administrators
- Develop and maintain understanding of site strategy, capabilities, and opportunities
- Align enterprise strategy with site goals
- Drive accountability for clinical trial enrollment performance
- Analyze enrollment trends and identify growth opportunities
- Develop and track strategic enrollment action plans
- Promote best practices supporting accrual
- Monitor and report on key performance indicators
- Translate enterprise priorities into site-level strategies
- Lead sites through change and transformation
- Elevate trends and insights to leadership
- Navigate high-impact or complex situations
- Use negotiation and conflict resolution to achieve outcomes
- Coordinate with internal teams to support site needs
- Ensure alignment across stakeholders
- Represent site perspectives in leadership forums
- Identify opportunities to improve processes and engagement
You should have for this position:
- Bachelor Degree required, master degree preferred
- Experience supporting oncology research sites and clinical trial enrollment
- Experience in site engagement, account management, or clinical operations
- Must have experience in clinical research operations
- Experience in oncology research
- Strategic relationship management skills
- Data analysis skills
- Excellent communication skills
- The ability to influence others
- Experience operating in a matrixed environment
Requirements
- Bachelor Degree required, master degree preferred
- Experience supporting oncology research sites and clinical trial enrollment
- Experience in site engagement, account management, or clinical operations
- Must have experience in clinical research operations
- Experience in oncology research
- Strategic relationship management skills
- Data analysis skills
- Excellent communication skills
- The ability to influence others
- Experience operating in a matrixed environment
Benefits
- Comprehensive benefits
- Physical well-being support
- Mental well-being support
- Financial well-being support
- Competitive compensation package
- Annual bonus
- Long-term incentive opportunities
Company overview
Sarah Cannon Research Institute (SCRI) is a premier oncology research organization and global leader in community-based clinical trials. Founded in 2004 through a joint venture between Tennessee Oncology and Hospital Corporation of America, SCRI has established itself as one of the world's leading cancer research institutions. With headquarters in Nashville, Tennessee, the institute operates across more than 200 locations in over 20 U.S. states and the United Kingdom, bringing together more than 1,300 research physicians. SCRI specializes in conducting first-in-human clinical trials, having completed over 850 such studies since its inception, and has contributed significantly to the development of approximately 10 FDA-approved cancer therapies since 1999. The organization focuses primarily on oncology research while also expanding into cardiology, gastroenterology, and other therapeutic areas. SCRI's unique community-based model enables patients to access cutting-edge clinical trials close to home, bridging the gap between academic research centers and local healthcare providers. The institute employs 501-1,000 professionals and maintains strategic partnerships with pharmaceutical and biotechnology companies to advance cancer treatment innovations.